“To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis”. 2024. Medical Forum Monthly 30 (9). https://medicalforummonthly.com/index.php/mfm/article/view/3872.